Cargando…
Correction: Vitamin D promotes the cisplatin sensitivity of oral squamous cell carcinoma by inhibiting LCN2-modulated NF-κB pathway activation through RPS3
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7078203/ https://www.ncbi.nlm.nih.gov/pubmed/32184381 http://dx.doi.org/10.1038/s41419-020-2389-0 |
| _version_ | 1783507568610508800 |
|---|---|
| author | Huang, Zixian Zhang, Yin Li, Haigang Zhou, Yufeng Zhang, Qianyu Chen, Rui Jin, Tingting Hu, Kaishun Li, Shihao Wang, Yan Chen, Weiliang Huang, Zhiquan |
| author_facet | Huang, Zixian Zhang, Yin Li, Haigang Zhou, Yufeng Zhang, Qianyu Chen, Rui Jin, Tingting Hu, Kaishun Li, Shihao Wang, Yan Chen, Weiliang Huang, Zhiquan |
| author_sort | Huang, Zixian |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7078203 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-70782032020-03-18 Correction: Vitamin D promotes the cisplatin sensitivity of oral squamous cell carcinoma by inhibiting LCN2-modulated NF-κB pathway activation through RPS3 Huang, Zixian Zhang, Yin Li, Haigang Zhou, Yufeng Zhang, Qianyu Chen, Rui Jin, Tingting Hu, Kaishun Li, Shihao Wang, Yan Chen, Weiliang Huang, Zhiquan Cell Death Dis Correction Nature Publishing Group UK 2020-03-17 /pmc/articles/PMC7078203/ /pubmed/32184381 http://dx.doi.org/10.1038/s41419-020-2389-0 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Correction Huang, Zixian Zhang, Yin Li, Haigang Zhou, Yufeng Zhang, Qianyu Chen, Rui Jin, Tingting Hu, Kaishun Li, Shihao Wang, Yan Chen, Weiliang Huang, Zhiquan Correction: Vitamin D promotes the cisplatin sensitivity of oral squamous cell carcinoma by inhibiting LCN2-modulated NF-κB pathway activation through RPS3 |
| title | Correction: Vitamin D promotes the cisplatin sensitivity of oral squamous cell carcinoma by inhibiting LCN2-modulated NF-κB pathway activation through RPS3 |
| title_full | Correction: Vitamin D promotes the cisplatin sensitivity of oral squamous cell carcinoma by inhibiting LCN2-modulated NF-κB pathway activation through RPS3 |
| title_fullStr | Correction: Vitamin D promotes the cisplatin sensitivity of oral squamous cell carcinoma by inhibiting LCN2-modulated NF-κB pathway activation through RPS3 |
| title_full_unstemmed | Correction: Vitamin D promotes the cisplatin sensitivity of oral squamous cell carcinoma by inhibiting LCN2-modulated NF-κB pathway activation through RPS3 |
| title_short | Correction: Vitamin D promotes the cisplatin sensitivity of oral squamous cell carcinoma by inhibiting LCN2-modulated NF-κB pathway activation through RPS3 |
| title_sort | correction: vitamin d promotes the cisplatin sensitivity of oral squamous cell carcinoma by inhibiting lcn2-modulated nf-κb pathway activation through rps3 |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7078203/ https://www.ncbi.nlm.nih.gov/pubmed/32184381 http://dx.doi.org/10.1038/s41419-020-2389-0 |
| work_keys_str_mv | AT huangzixian correctionvitamindpromotesthecisplatinsensitivityoforalsquamouscellcarcinomabyinhibitinglcn2modulatednfkbpathwayactivationthroughrps3 AT zhangyin correctionvitamindpromotesthecisplatinsensitivityoforalsquamouscellcarcinomabyinhibitinglcn2modulatednfkbpathwayactivationthroughrps3 AT lihaigang correctionvitamindpromotesthecisplatinsensitivityoforalsquamouscellcarcinomabyinhibitinglcn2modulatednfkbpathwayactivationthroughrps3 AT zhouyufeng correctionvitamindpromotesthecisplatinsensitivityoforalsquamouscellcarcinomabyinhibitinglcn2modulatednfkbpathwayactivationthroughrps3 AT zhangqianyu correctionvitamindpromotesthecisplatinsensitivityoforalsquamouscellcarcinomabyinhibitinglcn2modulatednfkbpathwayactivationthroughrps3 AT chenrui correctionvitamindpromotesthecisplatinsensitivityoforalsquamouscellcarcinomabyinhibitinglcn2modulatednfkbpathwayactivationthroughrps3 AT jintingting correctionvitamindpromotesthecisplatinsensitivityoforalsquamouscellcarcinomabyinhibitinglcn2modulatednfkbpathwayactivationthroughrps3 AT hukaishun correctionvitamindpromotesthecisplatinsensitivityoforalsquamouscellcarcinomabyinhibitinglcn2modulatednfkbpathwayactivationthroughrps3 AT lishihao correctionvitamindpromotesthecisplatinsensitivityoforalsquamouscellcarcinomabyinhibitinglcn2modulatednfkbpathwayactivationthroughrps3 AT wangyan correctionvitamindpromotesthecisplatinsensitivityoforalsquamouscellcarcinomabyinhibitinglcn2modulatednfkbpathwayactivationthroughrps3 AT chenweiliang correctionvitamindpromotesthecisplatinsensitivityoforalsquamouscellcarcinomabyinhibitinglcn2modulatednfkbpathwayactivationthroughrps3 AT huangzhiquan correctionvitamindpromotesthecisplatinsensitivityoforalsquamouscellcarcinomabyinhibitinglcn2modulatednfkbpathwayactivationthroughrps3 |